Business
Oxford-AstraZeneca vaccine is cheaper than Pfizer’s and Moderna’s and doesn’t require supercold temperature – The Conversation US
There is now a third vaccine that prevents COVID-19 infections. It isn’t quite as effective as the other two vaccines but it has advantages that may make it the…
The biopharmaceutical company AstraZeneca has released data on what is now the third promising vaccine candidate against COVID-19 and it has several advantages over those of its competitors, Pfizer and Moderna.
On Monday, AstraZeneca released interim analysis of its phase 3 trial data of 23,000 volunteers from the U.K. and Brazil. These results show that the test vaccine is between 70% and 90% effective in stopping COVID-19, depending on the vaccine doses administered. Although less effective than…
-
Noosa News17 hours agoBlute’s Bar Is Picking Up Where The Bearded Lady Left Off, Adding Live Music to Its Late-Night Karaoke Sing-Alongs
-
Business16 hours ago3 ASX 200 shares to buy for the year ahead
-
General22 hours agoTrump meeting cancellation ‘always a chance’: treasurer
-
Noosa News23 hours agoQueensland captain Cameron Munster hoping to emulate Cameron Smith’s legacy in debut as State of Origin leader